|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary and Critical Care, Harvard Medical School, Brigham and Womens Hospital, Boston, MA
Correspondence to: John J. Reilly, Jr, MD, FCCP, Associate Professor of Medicine, Harvard Medical School, Brigham and Womens Hospital, 7S Francis Street, Boston, MA 02115.
| Abstract |
|---|
|
|
|---|
O2 of < 1015 mL/kg/min or a
predicted postoperative M
O2 < 10 mL/kg/min
identifies a patient at very high risk for complications and
mortality. 5. Limited available data support the use of
preoperative risk indices to identify patients at high risk (See Table 4
). 6. Lung volume reduction surgery may provide new
approaches in selected patients with significant obstructive lung
disease and concomitant lung
cancer.
|
| Introduction |
|---|
|
|
|---|
Gass and Olsen, Chest 1986; 89:127135
The assessment of patients with known or suspected lung cancer is a common clinical situation for pulmonologists and internists. Almost all patients with lung cancer have a history of cigarette smoking, which puts them at risk for other conditions that may potentially affect operative risk, including chronic obstructive pulmonary disease and coronary artery disease. Patients with symptomatic chronic obstructive pulmonary disease have an increased risk for lung cancer relative to smokers without lung disease. Thus, clinicians are frequently called upon to evaluate the risks and feasibility of thoracotomy in patients with comorbid conditions.
In addition to defining the clinical stage of the known or possible lung cancer, preoperative evaluation has the goal of estimating the risk of the planned surgery. The risks associated with thoracotomy can be divided into two categories: immediate or short-term risk, which refers to perioperative morbidity and mortality, and long-term risk, which primarily indicates activity limitation resulting from lung resection.
Much of clinical practice concerning preoperative evaluation of candidates for thoracotomy is based upon clinical experience. Few prospective trials critically examined the various criteria used in preoperative assessment. Rather, clinical guidelines have been adopted that have subsequently identified patients who tolerate thoracotomy with "acceptable" risk.1 There are far fewer data about the converse, that is patients who have clearly unacceptable risk. Indeed, there are many reports in the literature documenting the ability of certain patients with one or more contraindications to thoracotomy who tolerated the procedure without adverse consequences.
There are two components in the assessment of patients considering thoracotomy. The first is an assessment of operative risk that any patient contemplating a major surgical procedure must undergo, including an assessment of cardiac risk.2 A consideration unique to the evaluation of patients considered for thoracotomy is the effect of pulmonary parenchymal resection on postoperative pulmonary function and, consequently, exercise capacity.3 4 5
| What Predicts Short-Term Risk? |
|---|
|
|
|---|
| Factors That Identify "Low Risk" Patients: |
|---|
|
|
|---|
MVV > 50% predicted
Predicted postoperative FEV1 > 0.8 L and 40% predicted
absence of cardiac disease
| Proposed Factors That Identify "High Risk" Patients |
|---|
|
|
|---|
PO2 < 50
Predicted Postoperative FEV1 < 0.7 L and/or 40% predicted
Age > 70
Poor exercise performance
| Predicting Postoperative Pulmonary Function |
|---|
|
|
|---|
Certain patients require additional testing to accurately predict postoperative function. These tests include bronchospirometry, lateral position testing, pulmonary lobar artery occlusion, and quantitative radionuclide scanning. It has been clearly established that a quantitative analysis of a radionuclide pulmonary perfusion scan provides enough information to allow accurate prediction of postoperative function.6 7 This is most clearly established with respect to FEV1 (reviewed in reference 4).
| Indications for Quantitative Radionuclide Scanning |
|---|
|
|
|---|
Known or suspected endobronchial obstruction
Significant hilar disease (mass/adenopathy)
Significant pleural disease
Selected patients who have had prior resections
| Evidence Supporting the Ability to Identify High Risk Patients |
|---|
|
|
|---|
There is evidence, including our own experience, that patients with a lower ppo FEV1 are at higher risk for complications and death, although the risk is still considered by many to be "acceptable."5 A number of reports exist establishing the ability to operate on selected patients with low pulmonary function.5 10 11 The most recent examples include the combination of lung volume reduction surgery with resection of lung cancer, in which the patient may recover with pulmonary function that is improved over that measured preoperatively.12
Given that the two largest categories of complications after thoracotomy are pulmonary and cardiac, it makes sense to identify patients at risk by assessing both of these systems. This is most easily accomplished by preoperative testing that involves the function of both systems and is best determined by some form of exercise. The available options for such an assessment include self-reporting by patients of activity capability, a timed walking test (6- or 12-min walk), stair climbing, and integrative cardiopulmonary exercise testing with expired gas analysis. The latter allows determination of maximal oxygen uptake (expressed as mL/min, mL/min/kg, or as % predicted). Of these approaches, the bulk of published data concerns the latter two approaches and is summarized in Tables 1 and 2. These data suggest that, in selected patients, exercise assessment may play a useful role in identifying patients at unacceptably high risk for surgery. More recently, this has been extended to calculate predicted postoperative maximal oxygen consumption and to assess candidate suitability for surgery.13
|
|
|
| Footnotes |
|---|
O2 = maximal oxygen uptake | References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
G. Olgac, A. Olcmen, and C. A. Kutlu Is lactate dehydrogenase level really a reliable predictor of pulmonary morbidity than other co-morbid parameters following lung resection for NSCLC? Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 732 - 733. [Full Text] [PDF] |
||||
![]() |
Y. Ohno, H. Hatabu, T. Higashino, D. Takenaka, H. Watanabe, Y. Nishimura, M. Yoshimura, and K. Sugimura Dynamic Perfusion MRI Versus Perfusion Scintigraphy: Prediction of Postoperative Lung Function in Patients with Lung Cancer Am. J. Roentgenol., January 1, 2004; 182(1): 73 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Varela, M. F. Jimenez, N. Novoa, and P. Macri Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 138 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beccaria, A. Corsico, P. Fulgoni, M. C. Zoia, L. Casali, G. Orlandoni, and I. Cerveri Lung Cancer Resection : The Prediction of Postsurgical Outcomes Should Include Long-term Functional Results Chest, July 1, 2001; 120(1): 37 - 42. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |